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Background: Neurological paraneoplastic syndromes are rarely the first manifestation of an underlying cancer. A
high index of suspicion is thus needed to diagnose such conditions. Paraneoplastic limbic encephalitis is one such
entity which is well described in association with small cell lung cancers, testicular germ cell tumors, breast cancers
and ovarian tumors. This article describes the entity being associated with an ovarian tumor.
Case: A 36-year-old female presented with abnormal behaviour, mood swings and delusions. She was evaluated for
her psychiatric symptoms and found to have an underlying ovarian tumor. Anti-NMDA receptor titers were strongly
positive. She underwent oophorectomy, and post-operatively there was a significant improvement in her psychiatric
symptoms.
Conclusions: Ovarian tumors like teratomas are implicated in the pathogenesis of paraneoplastic limbic
encephalitis. An underlying ovarian tumor must be evaluated in all young females presenting with sudden onset of
psychiatric symptoms.
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Paraneoplastic limbic encephalitis (PLE) was first described
by Corsellis et al. [1]. This entity was initially described in
association with brainstem dysfunction affecting older in-
dividuals with lung cancer. Subsequent studies, however,
have defined PLE in association with germ-cell tumors
with dominant limbic, diencephalic and upper brainstem
dysfunction [2]. Anti-N-methyl-D-aspartic (NMDA) re-
ceptor (NMDAR) encephalitis is one such acute, and a
potentially lethal, form of limbic encephalitis. It was
described as a distinct disease entity by Dalmau et al. in
2006. More than half of the cases described have a para-
neoplastic association with tumors, especially ovarian
teratomas [3]. The frequency of this disorder is largely
unknown [4].
Case presentation
A 36-year-old married female with no comorbidities
presented with a history of abnormal behaviour of five
weeks which included mood liability (laughing/crying
spells), delusions of persecution (feeling that other* Correspondence: drgopinath1@hotmail.com
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unless otherwise stated.people were trying to harm her), irritability and occasions
of talking to herself. She also had urinary and fecal incon-
tinence. For these complaints, she was shown to a psych-
iatrist, who evaluated her and started her on anti-psychotic
drugs. However, even with adequate doses of medications,
the symptoms worsened. An organic brain pathology was
therefore suspected, and she was referred to a neurologist.
Blood tests, which included tests for serum electrolytes,
viral markers, thyroid profile and anti-phospholipid anti-
bodies (APLA), anti-nuclear antibodies (ANA) and anti-
nuclear cytoplasmic antibodies (ANCA) were normal. A
magnetic resonance imaging (MRI) brain scan and an
electroencephalogram (EEG) were also normal. However,
anti-NMDA antibody titers were strongly positive.
Thus, a diagnosis of anti-NMDA autoimmune enceph-
alitis was made. She was started on steroids at a dose of
1 g/day. However, symptomatic improvement was minimal.
A paraneoplastic association was suspected, and a
computerized tomography (CT) scan of her abdomen
was done which showed a 8.3 × 6.9 × 5.3 cm heterodense
lesion arising from her right ovary with calcification
suggestive of a dermoid cyst. She was then referred to
us for surgical management of the adnexal lesion. On
examination, our patient was fidgety and restless with
poor word output. There was no eye-to-eye contactl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 Specimen photograph. The excised right ovarian tumor,
measuring 8.5 cm.
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(MMSE) showed a score of 4 out of 30. She was not even
able to walk or to write legibly. Our patient underwent a
right oophorectomy under general anesthesia (Figure 1).
The tumor grossly measured 8.5 cm in the largest dimen-
sion (Figure 2). On sectioning, sebaceous material and
hair were seen (Figures 3 and 4), suggesting an ovarian
teratoma.
Post-operatively, our patient was on a ventilator for two
days. Later she was transferred to ward and managed with
anti-epileptics and steroids. By the end of the first week,
she was able to talk with her family members and ask for
food and water; by the 10th day, she was making eye-to-
eye contact during conversations with good word output;
by the 20th day, she was able to climb four flights of stairs
and write legibly; by the end of one month, she was doing
her household chores and office work; her MMSE score
had improved to 26 out of 30.
Discussion
Pathophysiology
Anti-NMDAR encephalitis is mediated by auto-antibodies
against the NR1/NR2 subunits of the receptor [5]. NMDA
receptors are heterodimers of NR1 and NR2 subunits,
with both subunits being required to create a functional
receptor [4]. Physiologically, the NMDA receptor is im-
portant for synaptic plasticity and, in turn, is responsible
for higher functions such as learning and memory [5].
The pathogenesis involves autoimmune over expression
of NR2 subunits by nerve tissues in the teratomas that
lead to a break in the immune tolerance. Associated
factors such as a prodromal viral-like illness and genetic
factors may play additional roles in the initiation of an
immune response [4]. Inhibition of NMDA receptors
by these auto-antibodies leads to a reduced gamma-
aminobutyric acid (GABA) release in presynaptic neuronsFigure 1 Intra-operative photograph. The tumor arising from the
right ovary.that in turn switches off the inhibitory effects of glutamate
release in the postsynaptic neurons of the prefrontal or sub-
cortical areas, thereby contributing to the development of
psychosis and dyskinesias. The clinical manifestations vary
according to the receptor subtype to which the antibodies
bind. Binding to the NR1 subunit leads to hypoventilation,
while binding to the NR2A subunit leads to amnesia.
About 60% of patients with PLE have an underlying
tumour. As stated earlier, most commonly the cause is an
ovarian teratoma, but tumours such as testicular terato-
mas and small cell lung cancers have also been associatedFigure 3 Specimen photograph (cut section). Grey-white tumor
with cystic areas.
Figure 4 Specimen photograph (cut section). Sebaceous material and tufts of hair (arrow) are seen on closer inspection.
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cases of anti-NMDAR encephalitis [6].
Clinical features
This entity has been typically described: 18 years to
30 years female patients present with a characteristic
neuropsychiatric syndrome of personality and behavioral
changes, paranoia and memory disturbances [3]. Such
patients are often mistaken for psychiatric patients and
are often admitted to psychiatric centers [4]. Later during
the course of the illness, multiple neurological deficits,
dystonias, dyskinesias, seizures, autonomic instability and
clouding of consciousness occur [3,4]. Orofacial dyskine-
sias (jaw opening and closing, chewing, teeth clenching,
facial grimacing, lip pouting) and tongue protrusion are
characteristic features of this illness [5]. Once seizures are
controlled, any attempts to decrease the sedation or wean
patients off the ventilator lead to are appearance or
worsening of the abnormal movements [4]. Central
hypoventilation can occur in those with brainstem
and/or hypothalamus involvement.
Iizuka et al. have grouped the symptoms of anti-NMDAR
encephalitis into five characteristic phases: prodromal,
psychotic, unresponsive, hyperkinetic and gradual recov-
ery [5]. Clinical recognition of this syndrome is important
for two reasons: 1) the sub-acute presentation in a young
woman often leads to an initial diagnosis of acute psych-
osis, malingering or drug abuse, and 2) despite the severity
of symptoms, patients usually recover [2].
In our case, the patient had some of the above-
mentioned features in addition to bowel and bladder
incontinence.
Diagnosis
Diagnosis is often difficult, requiring certain tests to rule
out other causes of encephalitis. These include a cerebro-
spinal fluid (CSF) examination that shows pleocytosis or in-
creased protein concentration, suggesting an inflammatory
or immune-mediated neurological process [4]. A MRI scanis often unrevealing; although some patients (55%) [3,5]
have increased signals on FLAIR or T2W images in the
medial temporal lobes followed by the cerebral cortices,
cerebellum, brainstem and basal ganglion,these findings
are non-specific and correlate poorly with symptoms. Ab-
normalities in EEGs are seen in only 21% of patients, the
usual finding being generalized or predominantly fronto-
temporal slow waves [5]. Recently, a unique EEG pattern
has been identified in this condition called ‘extreme delta
brush’, which is a pattern of waveforms resembling those
seen in premature babies and this pattern is associated
with a prolonged illness [7]. The definitive diagnosis is
based on NMDAR antibodies identified in serum or CSF
[3]. Antibody titres in CSF are usually higher than in the
serum and correlate well with clinical symptoms. No false
positive results have been reported to date [5].
In our case, the CSF showed pleocytosis, the EEG was
abnormal, the MRI scan was normal and antibody titers
to NMDAR were high.
Thus, a diagnosis of PLE is made based on the following
criteria [8]:
1. Compatible clinical picture.
2. An interval of < 4 years between the development of
neurological symptoms and tumour diagnosis.
3. Exclusion of other neuro-oncological complications.
4. At least one of the following: CSF with inflammatory
changes but negative cytology; MRI demonstrating
temporal lobe abnormalities; EEG showing epileptic
activity in the temporal lobes.
Differential diagnosis
An important diagnosis that should be kept in mind and
excluded is herpes simplex encephalitis [9]. This often
presents with cognitive changes, seizures, tremors, myoclo-
nus and stroke-like symptoms and is characterized by a re-
lapsing course. Other entities included in the differential
diagnosis are prion diseases, autoimmune vasculitides,
systemic autoimmune diseases and steroid-responsive
Kattepur et al. World Journal of Surgical Oncology 2014, 12:256 Page 4 of 5
http://www.wjso.com/content/12/1/256encephalopathy associated with autoimmune thyroiditis.
The wide range of abnormal movements and prominent
orofacial involvement that remain even when the conscious
level is low, and the resistance to treatment, together with
psychiatric symptoms, autonomic features and central
hypoventilation, distinguish anti-NMDAR encephalitis from
other types of paraneoplastic encephalitis [5].
Treatment
The treatment of PLE includes corticosteroids, intraven-
ous IgG (IVIG) and occasionally plasma exchange [9]
along with antiepileptic medications, sedation, mechan-
ical ventilation, nutritional support and management of
episodes of autonomic instability and dyskinesias. Some
patients have transient (usually partial) improvement;
such patients are often discharged without a final diagno-
sis and they are the subset of patients who subsequently
deteriorate or succumb if the ovarian tumor has not been
removed [4]. Early recognition and treatment appears to
be critical to achieve a favorable outcome. Also one
should not wait for a positive NMDAR antibody result,
which can take up to several weeks to be processed. The
importance of initiating aggressive immunomodulatory
therapy even without evidence of a tumour cannot be
overemphasized, and it strongly argues against the use of
empiric ovarian resections, which has been advocated by a
few [3]. Surgical treatment is straightforward and involves
removal of the ovarian tumour. Since most of the patients
are young adult women, preservation of reproductive
function should be the goal. During surgery, propofol is a
more appropriate anaestheticto be used for such patients.
On the contrary, volatile anesthetics may suppress the im-
mune response more potently compared with propofol
and must be avoided [6]. Recovery during the post-
operative period is often slow, and weaning of the patient
off the ventilator must be judiciously interpreted with clin-
ical parameters. However, some patients show ventilator
dependence and need prolonged ventilator support.
Prognosis and outcome [4,5,10,11]
Overall, the prognosis is good (with paraneoplastic anti-
NMDAR encephalitis having a better prognosis than
most other paraneoplastic encephalitides and in those
with an associated malignancy than those without any
association), with nearly half the patients making a full
recovery and a quarter of them having only mild residual
deficits. However, 25% of patients may have severe re-
sidual deficits or eventually succumb to the disease
process. The outcome is better for those who undergo
early tumor removal, especially if this is done within
four months of the onset of symptoms.
The importance of tumor excision is also suggested, as
patients who do not undergo excision develop recurrent
neurological symptoms heralding a tumor recurrence.Further, dramatic recovery can occur in some patients,
as was seen in our patient, suggesting a potentially revers-
ible neuronal dysfunction. But, without surgical interven-
tion or with late tumor removal, the clinical course can be
prolonged or even fatal, with a mortality rate of around
4%. The usual causes include sepsis, cardiac arrest, acute
respiratory distress, refractory status epilepticus or sec-
ondary tumor progression.
Recovery occurs in the reverse order of symptom pres-
entation with autonomic and respiratory functions being
the first to recover, followed by the interactive and speech
functions. Social behaviour and executive function symp-
toms are usually the last to improve.
Conclusions
A paraneoplastic syndrome with an ovarian tumor should
always be in the differential diagnosis in a young woman
with new-onset psychiatric symptoms. The clinical im-
provement in these patients is slow even after tumor
excision. Early use of corticosteroids and IVIG may im-
prove the outcome, and early tumor removal improves
the prognosis.
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